Cancer is one of the leading causes of death in the world. Despite the growing number of cases, the cure for this lethal disease has not yet been discovered.

Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by researching and developing treatments for cancer and other severe, immune inflammatory conditions.

This innovative company seeks to deliver life-changing drugs for patients through more than three hundred clinical trials at major medical centers using compounds they produced. These patients may be afflicted with incurable hematological and solid tumor cancers, including multiple myeloma, lung cancer, and prostate cancer. As the manufacturer and distributor of these prescription drugs, Celgene alters the future by giving people another chance at life.

Celgene was initially founded in 1980 as a unit of Celanese Corporation. Six years later, Celgene was spun off as an independent pharmaceutical company. One of the company’s major milestones was the release of THALOMID (thalidomide), a prescription medication  for the acute treatment of erythema nodosum leprosum. They also received approval to market REVLIMID (lenalidomide) for the treatment of patients with transfusion-dependent anemia.

Recently, Celgene pumped forty-five million dollars into Quanticel, a San Francisco-based cancer drug start-up, to discover cancer drugs. With this partnership, Celgene can get an inside track on new cancer drug discoveries made by the smaller company. This is just one of the many initiatives Celgene uses to leverage their efforts in finding a suitable cure for the disease.

Aside from their commitment to clinical accomplishment, Celgene also considers patient support a guiding principle. They believe that people who could benefit from their groundbreaking discoveries should be given such an opportunity. Through industry-leading programs that provide information and access to their innovative therapies, Celgene puts patients at the top of their list of priorities.

As one of the most innovative companies in the field of medicine, Celgene plays an important role in changing the future of the medical industry.